124 related articles for article (PubMed ID: 32700769)
1. Time-dependent changes in proliferation, DNA damage and clock gene expression in hepatocellular carcinoma and healthy liver of a transgenic mouse model.
Hassan SA; Schmithals C; von Harten M; Piiper A; Korf HW; von Gall C
Int J Cancer; 2021 Jan; 148(1):226-237. PubMed ID: 32700769
[TBL] [Abstract][Full Text] [Related]
2. Does timing matter in radiotherapy of hepatocellular carcinoma? An experimental study in mice.
Hassan SA; Ali AAH; Sohn D; Flögel U; Jänicke RU; Korf HW; von Gall C
Cancer Med; 2021 Nov; 10(21):7712-7725. PubMed ID: 34545699
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma.
Liang Y; Wang S; Huang X; Chai R; Tang Q; Yang R; Huang X; Wang X; Zheng K
Comput Math Methods Med; 2021; 2021():8238833. PubMed ID: 34745328
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.
Korkusuz H; Knau L; Kromen W; Huebner F; Hammerstingl R; Lindemayr S; Bihrer V; Piiper A; Vogl TJ
Cancer Imaging; 2012 Mar; 12(1):72-8. PubMed ID: 22418445
[TBL] [Abstract][Full Text] [Related]
5. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo.
Stein TJ; Bowden M; Sandgren EP
Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452
[TBL] [Abstract][Full Text] [Related]
6. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
7. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.
Hui L; Zatloukal K; Scheuch H; Stepniak E; Wagner EF
J Clin Invest; 2008 Dec; 118(12):3943-53. PubMed ID: 19033664
[TBL] [Abstract][Full Text] [Related]
9. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma.
Yu C; Yang SL; Fang X; Jiang JX; Sun CY; Huang T
Mol Med Rep; 2015 May; 11(5):4002-8. PubMed ID: 25591621
[TBL] [Abstract][Full Text] [Related]
11. PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.
Lin X; Yang Y; Guo Y; Liu H; Jiang J; Zheng F; Wu B
Cancer Med; 2019 Sep; 8(12):5702-5715. PubMed ID: 31385458
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
Ritorto MS; Rhode H; Vogel A; Borlak J
Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of metallothionein and circadian genes in human hepatocellular carcinoma.
Li H; Lu YF; Chen H; Liu J
Chronobiol Int; 2017; 34(2):192-202. PubMed ID: 27997226
[TBL] [Abstract][Full Text] [Related]
14. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
15. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
[TBL] [Abstract][Full Text] [Related]
16. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
17. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
[TBL] [Abstract][Full Text] [Related]
18. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
[TBL] [Abstract][Full Text] [Related]
19. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
20. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression.
Llorente-Izquierdo C; Mayoral R; Cucarella C; Grau C; Alvarez MS; Flores JM; García-Palencia P; Agra N; Castro-Sánchez L; Boscá L; Martín-Sanz P; Casado M
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():106-15. PubMed ID: 23579063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
